Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This is a IIa phase IIa open-label, non-randomized clinical trial of Antroquinonol, capsule,
100 mg (Golden Biotechnology Corporation, Taiwan) in patients with AML.